Unique Aspects of the Design of Phase I/II Clinical Trials of Stem Cell Therapy-Reference-Cited by-同舟云学术

Unique Aspects of the Design of Phase I/II Clinical Trials of Stem Cell Therapy

Published:2018-06-06 Issue: Volume: Page:
ISSN:
Container-title:The Management of Clinical Trials
language:
Short-container-title:

Author:

Schulman Ivonne H.,Balkan Wayne,Saltzman Russell,DaFonseca Daniel,Caceres Lina V.,Delgado Cindy,Pujol Marietsy V.,Ramdas Kevin N.,Tovar Jairo,Vidro-Casiano Mayra,Hare Joshua M.

Publisher

InTech

Link

http://www.intechopen.com/download/pdf/58531

Reference148 articles.

1. Heldman AW, DiFede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial. Journal of the American Medical Association. 2014 Jan 1;311(1):62-73. DOI: 10.1001/jama.2013.282909

2. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. Journal of the American Medical Association. 2012 Dec 12;308(22):2369-2379. DOI: 10.1001/jama.2012.25321

3. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet. 2008 May 10;371(9624):1579-1586. DOI: 10.1016/S0140-6736(08)60690-X

4. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004 May 1;363(9419):1439-1441. DOI: 10.1016/S0140-6736(04)16104-7

5. Liang J, Zhang H, Hua B, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study. Annals of the Rheumatic Diseases. 2010 Aug;69(8):1423-1429. DOI: 10.1136/ard.2009.123463

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of extracellular vesicle-based medicinal products: A position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs – EVOLVE France”;Advanced Drug Delivery Reviews;2021-12

2. Human Mesenchymal Stem Cells for Spinal Cord Injury;Current Stem Cell Research & Therapy;2020-06-16

3. Mesenchymal Stromal Cells as a Therapeutic Intervention;Stromal Cells - Structure, Function, and Therapeutic Implications;2019-01-23